Impact of Preprocedural Anemia on Outcomes ofPatients With Mitral Regurgitation Who UnderwentMitraClip Implantation.

[1]  M. Peller,et al.  Anemia at Hospital Admission and Its Relation to Outcomes in Patients With Heart Failure (from the Polish Cohort of 2 European Society of Cardiology Heart Failure Registries). , 2017, The American journal of cardiology.

[2]  M. Neuss,et al.  Interaction between renal function and percutaneous edge-to-edge mitral valve repair using MitraClip. , 2017, Journal of cardiology.

[3]  S. Blankenberg,et al.  Baseline anemia and its impact on midterm outcome after transcatheter aortic valve implantation , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4]  M. Neuss,et al.  Prognostic Significance of Right Ventricular Dysfunction in Patients With Functional Mitral Regurgitation Undergoing MitraClip. , 2016, The American journal of cardiology.

[5]  M. Neuss,et al.  Impact of left ventricular systolic dysfunction on the outcomes of percutaneous edge-to-edge mitral valve repair using MitraClip , 2016, Heart and Vessels.

[6]  G. Giannakoulas,et al.  Is anemia a new cardiovascular risk factor? , 2015, International journal of cardiology.

[7]  T. Rassaf,et al.  Percutaneous mitral valve repair using the MitraClip system in patients with anemia. , 2015, International journal of cardiology.

[8]  R. Siegel,et al.  Impact of pulmonary hypertension on outcomes in patients with functional mitral regurgitation undergoing percutaneous edge-to-edge repair. , 2014, The American journal of cardiology.

[9]  M. Neuss,et al.  MitraClip in CRT non-responders with severe mitral regurgitation. , 2014, International journal of cardiology.

[10]  S. Blankenberg,et al.  Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. , 2014, Journal of the American College of Cardiology.

[11]  R. Habib,et al.  The independent effects of anemia and transfusion on mortality after coronary artery bypass. , 2014, The Annals of thoracic surgery.

[12]  J. Maessen,et al.  Prevalence, Factors Associated With, and Prognostic Effects of Preoperative Anemia on Short- and Long-Term Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation , 2013, Circulation. Cardiovascular interventions.

[13]  M. Ruel,et al.  Preoperative anaemia is a risk factor for mortality and morbidity following aortic valve surgery. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  J. Hausleiter,et al.  Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. , 2013, Journal of the American College of Cardiology.

[15]  M. A. Soliman Hamad,et al.  Preoperative hemoglobin level as a predictor of mortality after aortic valve replacement. , 2013, Journal of cardiothoracic and vascular anesthesia.

[16]  M. Neuss,et al.  Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure , 2013, European journal of heart failure.

[17]  K. Filion,et al.  Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. , 2013, American heart journal.

[18]  G. Pelissero,et al.  Impact of preoperative anemia on outcome in adult cardiac surgery: a propensity-matched analysis. , 2012, The Annals of thoracic surgery.

[19]  R. Wachter,et al.  Impact of the learning curve on outcomes after percutaneous mitral valve repair with MitraClip® and lessons learned after the first 75 consecutive patients , 2011, European journal of heart failure.

[20]  U. Dahlström,et al.  Brain natriuretic peptide‐guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome , 2011, European journal of heart failure.

[21]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[22]  P. Serruys,et al.  Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[23]  E. Foster,et al.  The acute hemodynamic effects of MitraClip therapy. , 2011, Journal of the American College of Cardiology.

[24]  Saibal Kar,et al.  Percutaneous repair or surgery for mitral regurgitation. , 2011, The New England journal of medicine.

[25]  B. Carabello.  Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery , 2011, Current cardiology reports.

[26]  R. Spence.  The economic burden of anemia in heart failure. , 2010, Heart failure clinics.

[27]  Antonio Colombo,et al.  Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting , 2010, European heart journal.

[28]  Scott Lim,et al.  Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. , 2009, Journal of the American College of Cardiology.

[29]  D. Wijeysundera,et al.  Risk Associated With Preoperative Anemia in Cardiac Surgery: A Multicenter Cohort Study , 2008, Circulation.

[30]  Sheena Derry,et al.  Prevalence of anaemia in older persons: systematic review , 2008, BMC geriatrics.

[31]  E. Foster,et al.  Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. , 2007, The American journal of cardiology.

[32]  E. Foster,et al.  Mitral valve hemodynamic effects of percutaneous edge‐to‐edge repair with the MitraClip™ device for mitral regurgitation , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[33]  J. Vila,et al.  Is pre-operative anaemia a risk marker for in-hospital mortality and morbidity after valve replacement? , 2006, European heart journal.

[34]  E. Foster,et al.  Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. , 2005, Journal of the American College of Cardiology.

[35]  R. Giugliano,et al.  Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes , 2005, Circulation.

[36]  L. Goodnough,et al.  Anemia of chronic disease. , 2005, The New England journal of medicine.

[37]  Luigi Ferrucci,et al.  Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. , 2004, Blood.

[38]  Samin K. Sharma,et al.  Anemia is an independent predictor of mortality after percutaneous coronary intervention. , 2004, Journal of the American College of Cardiology.

[39]  R. Levine,et al.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[40]  Paul W Armstrong,et al.  Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.

[41]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[42]  D. Rockey,et al.  Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. , 1993, The New England journal of medicine.

[43]  J. P. Araújo,et al.  Predictors of natriuretic peptide non-response in patients hospitalized with acute heart failure. , 2015, The American journal of cardiology.

[44]  Stamatios Lerakis,et al.  Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.